Skip to main content

What is the difference between Lonhala Magnair and Seebri Neohaler?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on Feb 10, 2025.

Official answer

by Drugs.com

Both Lonhala Magnair and Seebri Neohaler have been discontinued in the U.S., and a generic option is not available. Both products contained glycopyrrolate, a bronchodilator.

The primary difference between Lonhala Magnair and Seebri Neohaler was the dosage form and how they were administered to the patient.

  • Lonhala Magnair was delivered as a nebulized solution for inhalation via the Magnair nebulizer.
  • The Seebri Neohaler consisted of dry-powder inhalation capsules placed into a hand-held device and inhaled.

Both products were used twice daily (in the morning and evening) at the same time every day. These products contained glycopyrrolate, an anticholinergic, long-acting muscarinic antagonist (LAMA) bronchodilator for the treatment of chronic obstructive pulmonary disease (COPD) of the lung, including chronic bronchitis and/or emphysema.

Bronchodilators open and relax the airway passages in the lungs to improve breathing. This can help to prevent symptoms such as wheezing, coughing, chest tightness, and shortness of breath.

Related questions

How is Lonhala Magnair given?

The Lonhala Magnair technology was developed to allow a quiet, portable, closed system nebulizer that can deliver glycopyrrolate in 2 to 3 minutes with normal breathing while using the device. Each 1 mL unit-dose vial of the Lonhala Magnair aqueous solution contains 25 mcg of glycopyrrolate.

The Seebri Neohaler consisted of capsules that contained 15.6 mcg of glycopyrrolate and the hand-held inhalation device. The capsules are used in the device and not taken by mouth. They are inhaled twice daily (in the morning and evening), at the same time every day.

This is not all the information you need to know about Lonhala Magnair or Seebri Neohaler for safe and effective use. Review the full product and patient information and discuss this information and any questions you have with your doctor or other health care provider.

References
  • Drugs@FDA. FDA Approved Drugs. Accessed Feb 10, 2025 at https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm

Read next

Is Symbicort a steroid inhaler?

Symbicort contains an inhaled corticosteroid (“steroid”) known as budesonide to reduce inflammation in the lungs, but also contains a medicine known as formoterol. Formoterol is a long-acting inhaled bronchodilator that relaxes muscles in the airways to improve breathing. Continue reading

What foods should be avoided with COPD?

In some people, certain foods have been noted to aggravate symptoms of chronic obstructive pulmonary disease (COPD). These types of foods include: fried foods, carbonated beverages, excessively salty food or too much added salt, some dairy products, cruciferous vegetables (for example: kale, broccoli, cabbage) and preserved meats and cold cuts (with nitrates). Continue reading

What are the 4 stages of COPD?

COPD is now classified using grades, not stages. Grades of COPD are ranked from 1 to 4, ranging from mild to a very severe grade of lung disease based on your results from a breathing test called spirometry. Your healthcare provider may place you into a group (A to D) based on your current symptoms and your chances for flare-ups and hospitalizations. Continue reading

Related medical questions

Drug information

Related support groups